iDEL Therapeutics

KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity. The company's mission is to provide cancer patients with not only safe but also inexpensive immunotherapy, as well as to produce immunostimulatory drugs capable of preventing infectious illnesses.

Heidelberg Pharma GmbH, a drug development company, provides pre-clinical drug discovery and development services for the development of anti-cancer and anti-inflammatory drugs to pharmaceutical and biotechnology industries. It offers services, such as explorative pharmacology, drug metabolism and pharmacokinetics analysis, and molecular biology in the fields of oncology or inflammatory/autoimmune diseases.

Cellbox Solutions is a recently established technology firm that specializes in creative logistics solutions for the BioMed sector on a global scale.

Mainz Biomed strives to be a prominent supplier of accessible diagnostic solutions for individuals worldwide. Our focus is on creating inventive products that efficiently detect the early stages of various life-threatening illnesses, such as colorectal and pancreatic cancers. For additional information about our company and our commitment to using science to preserve lives, please visit our website at www.mainzbiomed.com.

Exciva develops clinical-stage biopharmaceutical therapies focused on addressing neuropsychiatric symptoms associated with dementia, including agitation and aggression in Alzheimer’s disease. It applies a targeted drug rescue approach that identifies and repurposes previously approved or clinically tested compounds into new therapeutic candidates. Exciva conducts scientific research and clinical studies to evaluate safety and potential effectiveness of its investigational products in neuropsychiatry. Its programs include formulations and methods designed for symptomatic relief and improved behavioral outcomes. Exciva collaborates with scientific and medical professionals to advance its pipeline through regulated trial phases and regulatory processes.

Amplifold is a biotech/medtech business that is developing next-generation quick diagnostic tests using DNA origami nanotechnology.

Impulse Dynamics is a medical device company dedicated to offering innovative solutions for treatment of Chronic Heart Failure (CHF). The Company’s developments are based on its proprietary technology for administering Cardiac Contractility Modulation therapy. This form of treatment has been shown in European clinical trials to produce an immediate and powerful modulating effect on cardiac cells, resulting in clinically meaningful increases incardiac performance. Impulse Dynamics is spearheaded by a team of professionals including, scientists, physicians, and engineers. The Company carries out research programs in major universities and hospitals throughout the world, and is currently engaged in clinical trials in Europe and in the United States. The Optimizer with Cardiac Contractility Modulation therapy, is CE marked. See Clinical Data for more information.

Tubulis creates specialized chemotherapy drugs that target cancer and chronic illnesses by combining unique technology with disease-specific biological knowledge. This allows medical professionals to treat cancer patients with fewer side effects than traditional chemotherapy.

Atai Life Sciences is a biotechnology company that develops therapies for mental health disorders. The company focuses on creating treatments using psychedelic compounds and other methods to address conditions such as depression, anxiety, and substance use disorders. Atai collaborates with various partners and research institutions to advance its drug development pipeline, which includes several clinical-stage programs. The product portfolio includes therapies that utilize research in psychedelics and neuroscience. Atai's lead programs feature ketamine-based treatments and other compounds aimed at improving mental well-being. The company works with experts in the field to ensure the efficacy and safety of its therapies. Atai Life Sciences has received recognition for its work in mental health treatment, securing partnerships and funding to support its research initiatives. The company has been acknowledged for its contributions to psychiatry and has gained attention for its efforts to advance the understanding and treatment of mental health disorders.

Vivoryon Therapeutics, a biopharmaceutical company headquartered in Germany, is dedicated to conducting research and development as well as preclinical and clinical trials. Their primary focus is on creating therapeutic treatments for Alzheimer's disease and cancer, with pipeline products such as PQ912, PQ1565, and other PQ-family medications.

Artcline is a biotech company that creates diagnostic and therapeutic techniques for critical care medicine.

Detechgene is a biotech firm that creates a cartridge system for conducting diagnostics.